Executive Director, National Accounts - Commercial Health Systems

1010 Genentech USA, Inc.; South San Francisco (CA); Vor Ort; USD 300.000 - 420.000; Vollzeit

Zusammenfassung

Genentech, a Roche subsidiary, seeks an Executive Director, National Accounts for Commercial Health Systems to lead a national portfolio and partner with health systems at the C-suite level. You will drive value creation across oncology, neurology, ophthalmology, immunology, and cardiovascular-renal-metabolism while focusing on patient access and cost-efficient care delivery.

The role emphasizes strategic alignment, enterprise capability deployment, and the management of large care-delivery

Qualifikationen

• Strategic leadership and advisory capability for health systems.
• Cross-functional governance and stakeholder management.
• Enterprise portfolio orchestration across multiple therapeutic areas.

Aufgaben

• Deliver executive leadership across national accounts and health systems.
• Drive alignment with CMG and other partners to optimize access strategies.
• Lead population health initiatives and enterprise-level partnerships to improve patient outcomes.

Jobbeschreibung

Executive Director, National Accounts - Commercial Health Systems Position Overview

From the beginning, Genentech has been a team of highly dedicated, passionate individuals united around a single purpose and an ambitious vision. Together, we aspire to deliver ever-better health outcomes for patients while lowering overall healthcare costs. The Opportunity Patients are counting on us. The Executive Director, National Accounts provides high-level strategic leadership across Genentech’s portfolio to close care gaps, enable product demand, and help patients start and stay on therapy. Operating in close partnership with major national care delivery organizations, this leader aligns enterprise capabilities to support the Quadruple Aim—improving patient outcomes, streamlining care delivery, supporting clinical teams, and driving health system efficiency. As the Executive Director, National Accounts – Commercial Health Systems, you will lead a team responsible for managing the nation’s largest commercial health systems, group purchasing organizations, and affiliated professional societies (e.g., HCA, CommonSpirit, Advocate, Vizient, The Resource Group, ACHE). This is a high-impact commercial leadership role. Operating in an environment where growth is driven through strategic alignment , your team’s mandate is to secure mindshare and drive enterprise-level alignment with health system C-suites through non-contractual value creation—co-creating outcomes frameworks, optimizing operational pathways, and deploying population health initiatives across Genentech’s high-value portfolio (Oncology, Neurology, Ophthalmology, Immunology, and Cardiovascular-Renal-Metabolism). Operating at an enterprise level, the Executive Director drives business performance, organizational impact, customer and patient outcomes, and nurtures team health.

To achieve these ambitious goals, the Executive Director will exemplify the following core capabilities and leadership approach:

• Strategic Consultative Mindset over Transactional Dealmaking: Views health systems through a management consulting lens rather than a vendor lens. Brings deep fluency in health system economics, operating margins, readmission penalties, HEDIS/Star quality metrics, and population health priorities, enabling them to coach the team on how to map biopharma capabilities (e.g., MS care path optimization) directly to C-suite operational goals.
• Mastery of Matrix Governance & Lateral Influence: Demonstrates a proven track record of leading cross-functional field teams without direct hierarchical authority—establishing clear governance rhythms, shared incentives, and peer accountability.
• Enterprise Portfolio Orchestration: Possesses the executive presence and strategic depth to elevate conversations beyond brand-level product pitches, coaching the team to orchestrate a multi-specialty portfolio across five complex therapeutic areas into a unified, high-value enterprise partnership with health system leadership.
• Bridge Between Strategy & Operational Execution: Recognizes the critical gap between C-suite intent and local facility workflows (EHR integration, clinical pathway compliance, local pharmacy governance), driving co-created account plans with measurable milestones that translate national alignment into sustainable facility-level pull-through.
• Drives an intentional focus on breaking down organizational silos to build a unified, collaborative culture where best practices are scaled, learning is accelerated, dots are connected across the healthcare ecosystem, and structured mechanisms exist for cross-functional knowledge sharing.
• Demonstrates the confidence to navigate complex stakeholder dynamics, hold challenging conversations, deliver direct feedback, and advocate for team priorities.
• Possesses the courage to respectfully push back with senior leadership, challenge existing team mindsets, and mobilize internal networks to drive superior business and individual outcomes.

National Leader Role Standards

• Deliver Business Performance and Organizational Impact
• Drive Patient Access: Deliver sustainable patient access (including formulary access, provider choice, and physical availability) while maintaining financial stewardship and product profitability consistent with therapeutic area goals.
• Cross-Functional Alignment: Build strategic relationships and lead national-level initiatives in partnership across Commercial, Medical, and Government (CMG) and other key functional partners to align national account access—compliantly driving push-through and pull-through access strategies.
• Portfolio & Enterprise Mindset: Evaluate complex trade-off decisions across therapeutic areas, ecosystems, regions, and national priorities in alignment with portfolio prioritization and the One Pharma Strategy.
• Value Proposition Delivery: Effectively communicate the clinical and value propositions of Genentech products (using on-label clinical data) to optimally position the portfolio for appropriate customer access.
• Executive Presence & Strategy Shaping: Influence leaders across CMG to shape strategies that thoughtfully account for customer business models, strategic priorities, and the overall customer experience.
• Outcome-Focused Resourcing: Evaluate, deploy, and align resources (headcount, operational spend, data insights) to drive maximum impact and inform strategic investment decisions.
• Deliver Customer and Patient Impact Market-Shaping Partnerships: Establish and leverage executive relationships with customer leadership on market-shaping topics, such as policy, market dynamics, and care delivery innovation.
• Digital & AI Integration: Lead and hold the team accountable for compliantly leveraging approved products, data insights, and emerging technology (including AI) to optimize efficiency, streamline workflows, and deliver a seamless, personalized customer experience.
• High-Performance Execution: Ensure team members compete at an elite level and consistently drive commercial results for the benefit of patients and key stakeholders.
• Ecosystem Evolution: Actively adapt to evolving marketplace dynamics and shape the Customer Engagement (CE) organization in alignment with broader CMG outcomes.
• Nurture Team Health Feedback & Learning Culture: Foster a culture of transparency and continuous learning by sharing and seeking feedback on market insights, negotiation strategies, and business learnings with national ecosystem/Leadership Teams (e/LT).
• Cross-Organizational Representation: Cultivate senior leadership relationships across Genentech and advocate for national team priorities when partnering with Squads and enterprise leaders